MedPath
HSA Approval

PREZEL 75 CAPSULE 75MG

SIN17143P

PREZEL 75 CAPSULE 75MG

PREZEL 75 CAPSULE 75MG

November 28, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N02BF02

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

IND-SWIFT LIMITED

Active Ingredients

Pregabalin

75 mg

Pregabalin

Documents

Package Inserts

PREZEL Capsule PI.pdf

Approved: November 28, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.